|
- Long-acting PrEP | APRETUDE (cabotegravir)
APRETUDE, long-acting injectable PrEP for HIV-1–negative at-risk adults adolescents weighing at least 77 lbs See Prescribing Info Boxed Warning
- What is APRETUDE? | APRETUDE (cabotegravir)
APRETUDE (cabotegravir), the 1st injectable PrEP option for HIV-1–negative at-risk adults adolescents weighing at least 77 lbs See Prescribing Info Boxed Warning
- Risks Side Effects | APRETUDE (cabotegravir)
Find information about the risks side effects for APRETUDE (cabotegravir) See Prescribing Info Boxed Warning
- FAQs | APRETUDE (cabotegravir)
Looking for more information about APRETUDE (cabotegravir)? Find answers to frequently asked questions about APRETUDE See Prescribing Info Boxed Warning
- Starting APRETUDE | APRETUDE (cabotegravir)
Find helpful tips for starting APRETUDE (cabotegravir) for PrEP for HIV-1–negative at-risk adults adolescents weighing at least 77 lbs See Prescribing Info Boxed Warning
- PrEP de acción prolongada | APRETUDE (cabotegravir)
APRETUDE es un medicamento recetado que se usa como PrEP del VIH 1 para reducir el riesgo de contraer la infección por VIH 1 en adultos y adolescentes que pesan al menos 77 libras (al menos 35 kg)
- PrEP Provider Locator | APRETUDE (cabotegravir)
Use our PrEP locator tool to find a doctor near you Search for healthcare providers or clinics educated about APRETUDE See Prescribing Info Boxed Warning
- Understanding HIV Risk | APRETUDE (cabotegravir)
What is the most important thing I should know about APRETUDE? Important information for people who receive APRETUDE for pre-exposure prophylaxis (PrEP) to help reduce their risk of getting human immunodeficiency virus-1 (HIV-1) infection: Before receiving APRETUDE to reduce your risk of getting HIV-1, you must be HIV-1 negative to start APRETUDE
|
|
|